• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

室上性心动过速药物治疗期间的致心律失常作用:窦性心律发生猝死的矛盾风险。

Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death.

作者信息

Prystowsky E N

机构信息

Clinical Electrophysiology Laboratory, Northside Cardiology and St. Vincent Hospital, Indianapolis, Indiana, USA.

出版信息

Am J Cardiol. 1996 Oct 17;78(8A):35-41. doi: 10.1016/s0002-9149(96)00564-4.

DOI:10.1016/s0002-9149(96)00564-4
PMID:8903274
Abstract

The purpose of this review is to summarize available data concerning proarrhythmia during drug therapy for supraventricular tachycardia. Patients were included in this review if 4 elements of treatment were available from the citation: (1) presence or absence of heart disease; (2) type of supraventricular tachycardia; (3) type of antiarrhythmic drug; and (4) type of proarrhythmic event. Citations spanning the years 1922-1995 yielded 56 reports and 195 events meeting the inclusion criteria. Atrial fibrillation was the most common arrhythmia and occurred alone in 76% of patients. Heart disease was present in 96% of patients. Proarrhythmic events were associated with 8 antiarrhythmic drugs in a total of 195 administered regimens. An adverse arrhythmic event was reported most frequently with quinidine (72%). Torsades de pointes was the most common of the documented proarrhythmic events (61%). Although supraventricular tachycardias are rarely in themselves life-threatening, symptoms may be disabling for many patients, and their lifestyle may be measurably improved by the maintenance of sinus rhythm. An algorithm is presented that takes into account the factors that predispose to proarrhythmia; it attempts to minimize the risk of treating these patients with antiarrhythmic drugs.

摘要

本综述的目的是总结有关室上性心动过速药物治疗期间致心律失常作用的现有数据。如果引用文献中包含治疗的4个要素,则将患者纳入本综述:(1)有无心脏病;(2)室上性心动过速的类型;(3)抗心律失常药物的类型;(4)致心律失常事件的类型。1922年至1995年的文献检索得到56篇报告和195例符合纳入标准的事件。心房颤动是最常见的心律失常,76%的患者单独发生。96%的患者存在心脏病。在总共195种给药方案中,致心律失常事件与8种抗心律失常药物有关。奎尼丁报告的不良心律失常事件最频繁(72%)。尖端扭转型室速是记录在案的最常见的致心律失常事件(61%)。虽然室上性心动过速本身很少危及生命,但症状可能使许多患者致残,维持窦性心律可显著改善他们的生活方式。本文提出了一种算法,该算法考虑了易发生致心律失常作用的因素;它试图将使用抗心律失常药物治疗这些患者的风险降至最低。

相似文献

1
Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death.室上性心动过速药物治疗期间的致心律失常作用:窦性心律发生猝死的矛盾风险。
Am J Cardiol. 1996 Oct 17;78(8A):35-41. doi: 10.1016/s0002-9149(96)00564-4.
2
Inpatient versus outpatient initiation of antiarrhythmic drug therapy for patients with supraventricular tachycardia.室上性心动过速患者抗心律失常药物治疗的住院起始与门诊起始
Clin Cardiol. 1994 Sep;17(9 Suppl 2):II7-10. doi: 10.1002/clc.4960171405.
3
[The pro-arrhythmic effects of anti-arrhythmia agents].[抗心律失常药物的促心律失常作用]
Z Kardiol. 1994;83 Suppl 5:75-85.
4
Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.尖端扭转型室速使低恶性心律失常的药物治疗复杂化:四例报告
Clin Cardiol. 1994 Apr;17(4):197-202. doi: 10.1002/clc.4960170410.
5
Avoiding drug problems. The safety of drugs for supraventricular tachycardia.避免药物问题。室上性心动过速药物的安全性。
Eur Heart J. 1997 May;18 Suppl C:C40-4. doi: 10.1093/eurheartj/18.suppl_c.40.
6
Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group.醋酸氟卡尼在室上性快速心律失常患者常规护理中的安全性和实用性:一项多中心试验的结果。氟卡尼室上性心动过速研究组
Am J Cardiol. 1996 Jan 25;77(3):72A-82A. doi: 10.1016/s0002-9149(97)89121-7.
7
Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group.接受恩卡胺和氟卡胺治疗的年轻患者出现的心律失常、心脏骤停及死亡。儿科电生理研究组
J Am Coll Cardiol. 1991 Aug;18(2):356-65. doi: 10.1016/0735-1097(91)90586-x.
8
[Antiarrhythmic therapy in patients with heart failure].心力衰竭患者的抗心律失常治疗
Ther Umsch. 2000 May;57(5):324-32. doi: 10.1024/0040-5930.57.5.324.
9
Clinical types of proarrhythmic response to antiarrhythmic drugs.抗心律失常药物致心律失常反应的临床类型。
Am J Cardiol. 1987 Apr 30;59(11):2E-9E. doi: 10.1016/0002-9149(87)90195-0.
10
Proarrhythmia: a paradoxic response to antiarrhythmic agents.致心律失常作用:抗心律失常药物的一种反常反应。
Pharmacotherapy. 1989;9(3):144-53. doi: 10.1002/j.1875-9114.1989.tb04120.x.

引用本文的文献

1
Pharmacological cardioversion of atrial fibrillation: current management and treatment options.心房颤动的药物复律:当前的管理与治疗选择
Drugs. 2004;64(24):2741-62. doi: 10.2165/00003495-200464240-00003.
2
Cost effectiveness of therapies for atrial fibrillation. A review.心房颤动治疗的成本效益。综述。
Pharmacoeconomics. 2000 Oct;18(4):317-33. doi: 10.2165/00019053-200018040-00002.
3
Atrial Fibrillation.
Curr Treat Options Cardiovasc Med. 2000 Aug;2(4):281-296. doi: 10.1007/s11936-996-0002-1.
4
In-hospital approach to newly recognized atrial fibrillation.
J Thromb Thrombolysis. 1999 Apr;7(2):123-9. doi: 10.1023/a:1008825318341.
5
Unexpected instant death following successful coronary artery bypass graft surgery (and other clinical settings): atrial fibrillation, quinidine, procainamide, et cetera, and instant death.冠状动脉搭桥手术成功后(以及其他临床情况)出现的意外猝死:心房颤动、奎尼丁、普鲁卡因胺等与猝死。
Clin Cardiol. 1998 Oct;21(10):711-8. doi: 10.1002/clc.4960211004.